Validation of the Performance of the French Version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a Screening Test for Cerebellar Cognitive-affective Syndrome: a National Multicenter Study (CCASS-FR)
Cerebellar Cognitive-affective Syndrome
About this trial
This is an interventional diagnostic trial for Cerebellar Cognitive-affective Syndrome focused on measuring Schmahmann syndrome, Cerebellar cognitive-affective syndrome, Screening
Eligibility Criteria
Inclusion criteria : French speaking Acquired lesion or predominantly degenerative cerebellar pathology of any etiology Affiliated or beneficiary of a social security scheme Written informed consent Non-inclusion criteria: History or progressive pathology of the central nervous system other than cerebellar disease Chronic ethylic patient with active consumption, or alcohol withdrawal of less than three months Use of other toxic substances Blind or severely visually impaired patient Deaf or severely hearing-impaired patient unable to understand instructions Mute patient Patient deprived of liberty or under legal protection Secondary exclusion criteria : - Patients with incomplete French scale and/or neuropsychological assessment will be replaced.
Sites / Locations
Arms of the Study
Arm 1
Other
Adults with a cerebellar damage